
Uganda’s Dei BioPharma Secures Landmark Ebola and Mpox mRNA Vaccine Patents
A defining moment for African health and scientific independence was announced at the 4th International Conference on Public Health in Africa (CPHIA 2025), as Dei BioPharma Founder Dr. Matthias Magoola revealed that the company has secured new patent rights for…
